Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid vs Topical 4% Hydroquinone in Melasma
IRCT20220709055422N1Phase 3Completed
- Sponsor
- Pak Emirates Military Hospital
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid and hydroquinone in melasma (2 arms), sponsored by Pak Emirates Military Hospital. Started Oct 2018; status: completed.
02
Drugs
tranexamic acidhydroquinone
03
Conditions
melasma
Beyond the preview
Go deeper on IRCT20220709055422N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220709055422N1.